| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 15, 2023 |
Chief Operating Officer
Trans History: 19
|
Chief Operating Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 120,000 | -- | 339,338 |
| Feb 15, 2023 |
Chief Operating Officer
Trans History: 19
|
Chief Operating Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 560,000 | -- | 560,000 |
| Feb 15, 2023 |
Chief Financial Officer
Trans History: 14
|
Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 105,000 | -- | 231,373 |
| Feb 15, 2023 |
Chief Financial Officer
Trans History: 14
|
Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 490,000 | -- | 490,000 |
| Aug 15, 2022 |
Director
Trans History: 11
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | 60,923 |
| Jul 07, 2022 |
Director
Trans History: 18
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 44,470 | -- | -- |
| Jun 09, 2022 |
Director
Trans History: 18
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 164,422 | -- | 164,422 |
| Jun 09, 2022 |
Director
Trans History: 11
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 164,422 | -- | 164,422 |
| Jun 09, 2022 |
Director
Trans History: 11
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 164,422 | -- | 164,422 |
| Jun 09, 2022 |
Director
Trans History: 9
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 164,422 | -- | 164,422 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.